diaziquone has been researched along with Carcinoma, Squamous Cell in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (71.43) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baylouny, RA; Bissell, EC; Holiat, SM; Hubert, DD; Smith, WE; Sobel, HJ; Watts, LM; Yazdi, E | 1 |
| Balcer-Kubiczek, EK; Eddy, HA; Harrison, GH | 1 |
| Ball, H; Blessing, JA; Rettenmaier, M; Slayton, RE | 1 |
| Becker, M; Bender, JF; Grillo-Lopez, AJ; Muñiz, F; Neidhart, JA; Vélez-García, E | 1 |
| Al-Sarraf, M; Ensley, J; Kish, JA | 1 |
| Blessing, JA; Malfetano, J; Slayton, RE; Stehman, FB | 1 |
| Creagan, ET; Edmonson, JH; Kvols, LK; Long, HJ; O'Fallon, JR | 1 |
7 other study(ies) available for diaziquone and Carcinoma, Squamous Cell
| Article | Year |
|---|---|
Complete remissions in chemotherapy of lung cancer models induced in mice by asbestos.
Topics: Animals; Antineoplastic Agents; Asbestos, Serpentine; Aziridines; Benzoquinones; Carcinoma, Squamous Cell; Cisplatin; Dianhydrogalactitol; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Mitoxantrone; Models, Animal; Nitrosourea Compounds; Pentostatin; Remission Induction; Survival Analysis; Triazines | 2005 |
Potentiation of chemotherapy by low-level ultrasound.
Topics: Animals; Antineoplastic Agents; Aziridines; Benzoquinones; Carcinoma, Squamous Cell; Cell Line; Cell Survival; Combined Modality Therapy; Cricetinae; Doxorubicin; Humans; In Vitro Techniques; Neoplasm Transplantation; Ultrasonic Therapy; Ultrasonics | 1991 |
A phase II clinical trial of diaziquone (AZQ) in the treatment of patients with recurrent adenocarcinoma and adenosquamous carcinoma of the cervix. A Gynecologic Oncology Group study.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Aziridines; Benzoquinones; Carcinoma, Squamous Cell; Drug Evaluation; Drugs, Investigational; Female; Humans; Middle Aged; Recurrence; Uterine Cervical Neoplasms | 1989 |
A phase II trial of diaziquone in patients with head and neck cancer.
Topics: Adult; Aged; Aziridines; Azirines; Benzoquinones; Carcinoma, Squamous Cell; Drug Evaluation; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged | 1987 |
Phase II evaluation of diaziquone in recurrent head and neck cancer.
Topics: Aged; Antineoplastic Agents; Aziridines; Azirines; Benzoquinones; Carcinoma, Squamous Cell; Drug Evaluation; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Risk | 1986 |
Phase II clinical trial of diaziquone in the treatment of patients with recurrent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study.
Topics: Adult; Aged; Aziridines; Azirines; Benzoquinones; Carcinoma, Squamous Cell; Drug Evaluation; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Uterine Cervical Neoplasms | 1986 |
Phase II trial of diaziquone in advanced upper aerodigestive cancer.
Topics: Adult; Aged; Antineoplastic Agents; Aziridines; Azirines; Benzoquinones; Carcinoma, Squamous Cell; Drug Evaluation; Female; Humans; Leukocyte Count; Male; Middle Aged; Mouth Neoplasms; Nausea; Otorhinolaryngologic Neoplasms; Platelet Count | 1985 |